Maureen Martino

Articles by Maureen Martino

ImmusanT lands $20M for celiac vaccine work

ImmusanT has won a big round of venture capital for its work on a vaccine for celiac disease. Vatera Healthcare Partners is putting up $20 million to help support clinical development of Nexvax2. A

Antigen Express vaccine cuts breast cancer recurrence

Generex Biotechnology subsidiary Antigen Express has reported promising early results in a Phase II trial of its breast cancer treatment. The vaccine, called AE37, cut the recurrence of breast cancer...

Gates Foundation gives Duke $24.6M for HIV vaccine research

The Bill and Melinda Gates Foundation has handed Duke University researchers $24.6 million over five years for work on developing a vaccine to prevent HIV. The funding is part of a larger $37.2...

Merck, NanoBio team on preclinical RSV deal

Ann Arbor, MI-based NanoBio Corporation said it's teaming up with an unnamed Merck subsidiary on preclinical development of an intranasal vaccine for Respiratory Syncytial Virus (RSV)....

EU wants power to negotiate flu vaccine prices

EU health chief John Dalli has proposed a measure that would allow the European Commission to bargain with Big Pharma to procure vaccines for its member states in future flu pandemics. "We...

Study: Afternoon vaccines may be better for babies

It's not unusual for babies to experience a poor night's sleep and fever after receiving their first round of immunizations. A new study published in the journal Pediatrics finds that infants were

LigoCyte posts positive results from norovirus vaccine trial

Bozeman, MT-based LigoCyte Pharmaceuticals announced that a Phase I/II trial of the company's vaccine protected recipients from norovirus infection, commonly referred to as the "stomach flu." The

Takeda unveils new vaccine business headed by Gates Foundation exec

Japan's Takeda has announced the company plans to launch a vaccine development business unit at the beginning of 2012. The new division will be headed up by Dr. Rajeev Venkayya, who's currently

88 drugs, vaccines filling HIV/AIDS pipeline

The FDA has approved more than 30 medicines to treat HIV/AIDS since the disease became widespread in the early 1980s. The life expectancy for many patients with the disease has increased considerably

Study: MDs often asked for alternative vaccine schedules

A study conducted by Seattle Children's Research Institute found that 77% of pediatricians in Washington state had been asked by parents to adjust their kids' vaccine schedule. Of the 209 physicians